Editas Medicine (EDIT) Reports Q4 Loss of $0.52/Share

Editas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($0.52), versus ($0.84) reported last year.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Aecon wins $1.7B share of Alberta power plant contract
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM